TEDCO’s Q1 Investments Top $2.7M to Fuel Innovation Across Maryland’s Diverse Startup Ecosystem TEDCO deployed more than $2.7M of diverse investments in Maryland’s burgeoning technology and biotech sectors, driving innovation [….]
TEDCO announces the release of the 2023 Economic Impact Study. With $2.7B in economic impact, more than 10,400 jobs continue to make significant economic and fiscal returns to Maryland’s ecosystem. In the latest report, TEDCO’s six core research and investment vehicles supported 442 portfolio companies, created more than 10,400 jobs, and had an economic impact of $2.7B.
UMB and UMBC to Launch New Baltimore Accelerator with Landmark NIH Grant
Empowering Growth: Bret Schreiber and Fulton Bank’s Impact on the BioHealth Capital Region By Sam Hopkins | October 17, 2023 Fulton Bank, a formidable financial institution with a rich history [….]
BioSpark Virginia is a competitive live pitch event for Virginia life sciences start-ups, co-sponsored and organized by CvilleBioHub and the University of Virginia Licensing and Ventures Group (LVG). After an [….]
FDA awards nearly $7.5 million to pediatric device consortium led by Children’s National Hospital Federal funding fosters the development and commercialization of medical devices designed for children. WASHINGTON, D.C. (Sept.19, [….]
Johns Hopkins Wilmer Eye Institute Receives $20 Million Donation from T. Boone Pickens Foundation Additional funding from the T. Boone Pickens Foundation will create additional Professorships for young researchers at [….]
It was a busy week for financing, partnerships and collaborations within the BioHealth Capital Region. TEDCO and the Lupus Foundation doled out several grant awards, while Emergent BioSolutions snagged a $704 Million BARDA contract. NIH also tapped a new NIAID director.
Charles River Labs to Open Accelerator and Development Lab in Philly, Penn Med and CHOP Receive $26 Million NIH Grant and more. Continue reading for these life science stories in the Philadelphia Region and more.
RTP’s life sciences ecosystem is bouncing back this week with the launch of a new company, Kincell Bio, as well as new financing announcements. Inceptor Bio spins out new company Kincell Bio, which aims to improve accessibility for cell therapy development and manufacturing. RedHill Biopharma and Kriya Therapeutics both announced new funding streams.
